Lasa Supergenerics Valuation
| LASA Stock | 26.58 1.26 4.53% |
At this time, the firm appears to be overvalued. Lasa Supergenerics secures a last-minute Real Value of USD22.58 per share. The latest price of the firm is USD26.58. Our model forecasts the value of Lasa Supergenerics from analyzing the firm fundamentals such as Return On Equity of -0.2, current valuation of 1.58 B, and Profit Margin of (0.19) % as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.5193 | Enterprise Value 1.6 B | Enterprise Value Ebitda (13.02) | Price Sales 1.3449 | Enterprise Value Revenue 1.3211 |
Overvalued
Today
Please note that Lasa Supergenerics' price fluctuation is not too volatile at this time. Calculation of the real value of Lasa Supergenerics is based on 3 months time horizon. Increasing Lasa Supergenerics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Lasa stock is determined by what a typical buyer is willing to pay for full or partial control of Lasa Supergenerics Limited. Since Lasa Supergenerics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lasa Stock. However, Lasa Supergenerics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.58 | Real 22.58 | Hype 26.58 | Naive 28.91 |
The intrinsic value of Lasa Supergenerics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lasa Supergenerics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Lasa Supergenerics Limited helps investors to forecast how Lasa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lasa Supergenerics more accurately as focusing exclusively on Lasa Supergenerics' fundamentals will not take into account other important factors: Lasa Supergenerics Cash |
|
Lasa Supergenerics Total Value Analysis
Lasa Supergenerics Limited is now projected to have takeover price of 1.58 B with market capitalization of 1.41 B, debt of 220.76 M, and cash on hands of 15.91 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Lasa Supergenerics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.58 B | 1.41 B | 220.76 M | 15.91 M |
Lasa Supergenerics Investor Information
About 63.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.52. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lasa Supergenerics recorded a loss per share of 4.54. The entity last dividend was issued on the 16th of September 2022. Based on the key indicators related to Lasa Supergenerics' liquidity, profitability, solvency, and operating efficiency, Lasa Supergenerics Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Lasa Supergenerics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Lasa Supergenerics has an asset utilization ratio of 69.16 percent. This implies that the Company is making USD0.69 for each dollar of assets. An increasing asset utilization means that Lasa Supergenerics Limited is more efficient with each dollar of assets it utilizes for everyday operations.Lasa Supergenerics Ownership Allocation
Lasa Supergenerics maintains a total of 50.1 Million outstanding shares. Lasa Supergenerics Limited secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 62.7 % of Lasa Supergenerics Limited outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Lasa Supergenerics Profitability Analysis
The company reported the revenue of 1.04 B. Net Loss for the year was (217.31 M) with profit before overhead, payroll, taxes, and interest of 220.46 M.About Lasa Supergenerics Valuation
The stock valuation mechanism determines Lasa Supergenerics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Lasa Supergenerics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lasa Supergenerics. We calculate exposure to Lasa Supergenerics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lasa Supergenerics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 287 M | 433.5 M |
Additional Tools for Lasa Stock Analysis
When running Lasa Supergenerics' price analysis, check to measure Lasa Supergenerics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lasa Supergenerics is operating at the current time. Most of Lasa Supergenerics' value examination focuses on studying past and present price action to predict the probability of Lasa Supergenerics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lasa Supergenerics' price. Additionally, you may evaluate how the addition of Lasa Supergenerics to your portfolios can decrease your overall portfolio volatility.